INJ
INJ
6.677
-17.41%
INJ
INJUSDT
6.648
-17.69%

On Wednesday, Injective put proposal #717 up for a vote, and by Saturday $INJ was trading near $7.97, up about 7.4% in 24 hours (CoinMarketCap), while Bitcoin lost 3%. Volume roughly doubled to about $168M. The rally stalled at $8.32, right at the ceiling traders have watched for weeks.

Here's how the week built up, and what's still on the calendar.


📅 THE TIMELINE

  • Nov 5. The Canary staked INJ ETF (ticker INJC) starts trading on Nasdaq. It holds about $16.1M in net assets a day later. Small, but it's the first US product of its kind for INJ.

  • Nov 12. The Veyra upgrade (IIP-717) goes to vote. It adds request-for-quote trading, wider atomic swaps, new IBC cross-chain functions and groundwork for CypherOS privacy tech. No change to supply or staking rewards.

  • Nov 13. dYdX publishes proposal v9.9 to move its USDC support from Noble to Injective-issued USDC, after Circle dropped USDC on Noble. About 84.56M USDC still sat on Noble as of Nov 11. Worth being clear: this is a new route for existing USDC, not direct INJ buying.

  • Nov 14. Turnout hits 34.78%, above the 33.4% quorum. Yes votes sit near 72.3%, abstain about 27.3%, no under 1%. Injective says over 99% of stakers who picked a side voted yes. Price tags $8.32 and pulls back toward $7.90.


📈 THE CHART

Coinpedia's daily chart shows an ascending triangle: higher lows since the August low near $3.95, and flat resistance at $8.20 to $8.28. Saturday's high poked just above it, then slipped back under.

  • Above: $8.32 (today's high), then $8.77, then $9.41 (October high).

  • Below: $7.56 (50-day EMA), $7.33 (0.382 Fibonacci), $6.69.

  • The 50-day EMA sits above the 200-day (~$6.28), a golden cross in place since early September.

Thursday's reading was about 48.7, neutral, before the move. Derivatives look calm. Open interest is around $70.1M and funding is slightly positive (+0.0065), so this wasn't a leverage blow-off.


✅ What supports it

  • Supply keeps shrinking: buybacks have burned more than 7.27M INJ (about $58M) as of Oct 22.

  • An upgrade aimed at institutional trading, plus dYdX routing USDC through Injective.

  • Strength on a day when most of the market was red.


⚠️ What could go wrong

  • Futures CVD was negative (about −$110.7M), so sellers were active into the spike.

  • Bitcoin sits at extreme fear. If $BTC loses $66K, few alts hold up.

  • Turnout cleared quorum by a thin margin, and the vote runs until Nov 16.


THREE SCENARIOS

  • 🟢 A daily close above $8.32 with volume holding up opens $8.77, then $9.41.

  • ⚪ Range between $7.56 and $8.32 while the vote finishes.

  • 🔴 A daily close under the 50-day EMA ($7.56) puts $7.33 and $6.69 back in view.


What the charts people say

  • Coinpedia's analysis frames $8.20 to $8.28 as the line bulls need, with the rising trendline as support.

  • Crypto News Flash marks $8.13, $8.77 and $9.41 as the resistance steps.


Coming up

  • Nov 16: Veyra vote and dYdX v9.9 vote close

  • Nov 17: dYdX upgrade, if approved

  • ~Nov 24: Veyra goes live at block 193,145,000 (v1.21.0)


My read

The news flow is real and dated, which is rare for an alt this month. Still, $INJ needs a daily close above $8.32 to turn a nice candle into a breakout. Until then it's a test, not a trend.


Pick one 👇 What moves INJ most into December?

  • A) Veyra going live

  • B) dYdX's USDC switch

  • C) Bitcoin's direction


#BTC #CryptoNews #Write2Earn #INJ #Injective

Educational content, not financial advice. DYOR.